カテゴリ： MarketLine, インド, 企業調査

General Insurance Corporation of India：企業の戦略・SWOT・財務情報

◆英語タイトル：General Insurance Corporation of India - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C14093
◆発行会社（調査会社）：MarketLine
◆発行日：2019年3月
◆ページ数：39
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：インド
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

General Insurance Corporation of India – Strategy, SWOT and Corporate Finance Report
Summary

General Insurance Corporation of India – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

General Insurance Corporation of India (GIC), a Government-owned company, is a provider of reinsurance products to the general insurers. It offers reinsurance product on both treaty and facultative basis. Its offerings include property reinsurance, energy reinsurance, marine reinsurance, engineering reinsurance, liability reinsurance and aviation reinsurance. The company also offers reinsurance products for agriculture/weather, health, spares, marine hull and cargo, offshore energy, motor and life. GIC operates in India, the Middle East region, ASEAN region, and UK and European Union countries. It has branches in Dubai, the UAE; Labuan, Malaysia; and London, the UK; and a representative office in Moscow. GIC is headquartered in Mumbai, Maharashtra, India.

The company reported gross premium of INR417,993.7 million for FY2018, an increase of 24.5% over that in FY2017. Its net premium was INR376,344.6 million in FY2018, an increase of 24.7% over that in FY2017.

Scope

- Detailed information on General Insurance Corporation of India required for business and competitor intelligence needs
- A study of the major internal and external factors affecting General Insurance Corporation of India in the form of a SWOT analysis
- An in-depth view of the business model of General Insurance Corporation of India including a breakdown and examination of key business segments
- Intelligence on General Insurance Corporation of India’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about General Insurance Corporation of India, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of General Insurance Corporation of India and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess General Insurance Corporation of India as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on General Insurance Corporation of India’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
General Insurance Corporation of India: Company Overview
General Insurance Corporation of India: Overview and Key Facts
General Insurance Corporation of India: Overview
General Insurance Corporation of India: Key Facts
General Insurance Corporation of India: Key Employees
General Insurance Corporation of India: Key Employee Biographies
General Insurance Corporation of India: Major Products and Services
General Insurance Corporation of India: Company History
General Insurance Corporation of India: Locations and Subsidiaries
General Insurance Corporation of India: Key Competitors
General Insurance Corporation of India: Company Analysis
General Insurance Corporation of India: Business Description
General Insurance Corporation of India: Corporate Financial Deals Activity
General Insurance Corporation of India: Financial Deals Overview
General Insurance Corporation of India: Targets and Partners
General Insurance Corporation of India: Top Deals 2015 – 2019YTD*
General Insurance Corporation of India: Advisors
General Insurance Corporation of India: Top Legal Advisors
General Insurance Corporation of India: Top Financial Advisors
General Insurance Corporation of India: Mergers and Acquisitions
General Insurance Corporation of India: Corporate Venturing
General Insurance Corporation of India: Capital Raising
General Insurance Corporation of India: Partnership
General Insurance Corporation of India: Divestments
General Insurance Corporation of India: Recent Developments
General Insurance Corporation of India: News and Events Summary
General Insurance Corporation of India: Business Expansion
General Insurance Corporation of India: Corporate Governance
General Insurance Corporation of India: Financial Deals
General Insurance Corporation of India: Financial Performance
General Insurance Corporation of India: Regulatory and Legal Events
General Insurance Corporation of India: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: General Insurance Corporation of India: Key Facts
Table 2: General Insurance Corporation of India: Key Employees
Table 3: General Insurance Corporation of India: Company History
Table 4: General Insurance Corporation of India: Locations and Subsidiaries
Table 5: General Insurance Corporation of India: Key Competitors
Table 6: General Insurance Corporation of India: Deal Activity by Deal Type - Volume (TTM*)
Table 7: General Insurance Corporation of India: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: General Insurance Corporation of India: M&A Average Deal Size - Value (US$m)
Table 9: General Insurance Corporation of India: Targets and Partners
Table 10: General Insurance Corporation of India: Top Deals 2015 - 2019YTD*
Table 11: General Insurance Corporation of India: Legal Advisor Ranking by Value (US$m)
Table 12: General Insurance Corporation of India: Financial Advisor Ranking by Value (US$m)
Table 13: General Insurance Corporation of India: M&A Volume and Value Trend (2015 - YTD*2019)
Table 14: General Insurance Corporation of India: M&A Activity by Geography (2015 - YTD*2019)
Table 15: General Insurance Corporation of India: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 16: General Insurance Corporation of India: Corporate Venturing by Geography (2015 - YTD*2019)
Table 17: General Insurance Corporation of India: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Table 18: General Insurance Corporation of India: Capital Raising by Deal Type (2015 - YTD*2019)
Table 19: General Insurance Corporation of India: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 20: General Insurance Corporation of India: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 21: General Insurance Corporation of India: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 22: General Insurance Corporation of India: Divestments by Geography (2015 - YTD*2019)
Table 23: General Insurance Corporation of India: News and Events Summary
Table 24: General Insurance Corporation of India: Business Expansion
Table 25: General Insurance Corporation of India: Corporate Governance
Table 26: General Insurance Corporation of India: Financial Deals
Table 27: General Insurance Corporation of India: Financial Performance
Table 28: General Insurance Corporation of India: Regulatory and Legal Events
Table 29: General Insurance Corporation of India: Strategy and Operations

List of Figures
Figure 1: General Insurance Corporation of India: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: General Insurance Corporation of India: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: General Insurance Corporation of India: M&A Average Deal Size - Value (US$m)
Figure 4: General Insurance Corporation of India: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 5: General Insurance Corporation of India: M&A Activity by Geography (2015 - YTD*2019)
Figure 6: General Insurance Corporation of India: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 7: General Insurance Corporation of India: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 8: General Insurance Corporation of India: Capital Raising Volume and Value Trend (2015 - YTD*2019)
Figure 9: General Insurance Corporation of India: Capital Raising by Deal Type (2015 - YTD*2019)
Figure 10: General Insurance Corporation of India: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 11: General Insurance Corporation of India: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 12: General Insurance Corporation of India: Divestments Volume and Value Trend (2015 - YTD*2019)
Figure 13: General Insurance Corporation of India: Divestments by Geography (2015 - YTD*2019)

★海外企業調査レポート[General Insurance Corporation of India：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Peco Energy Company-エネルギー分野：企業M&A・提携分析
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • Cameco Corporation：企業の戦略・SWOT・財務情報
    Cameco Corporation - Strategy, SWOT and Corporate Finance Report Summary Cameco Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Energir LP：企業の戦略的SWOT分析
    Energir LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Microbix Biosystems Inc (MBX)：企業の財務・戦略的SWOT分析
    Summary Microbix Biosystems Inc (Microbix) provides biological and technology solutions for human health and wellbeing. The company's products include infectious disease antigens and quality assessment products. It manufactures viral and bacterial antigens and reagents for the diagnostics. Microbix …
  • Landis+Gyr AG-エネルギー分野：企業M&A・提携分析
    Summary Landis+Gyr AG (Landis+Gyr) is an integrated energy management company that provide end-to-end advanced metering solutions. It delivers comprehensive services including cloud services, managed services, smart grid services, software services, solutions consulting and support services. The com …
  • Fuji Electric Co., Ltd.：企業の戦略・SWOT・財務情報
    Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Fuji Electric Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Novo Nordisk AS (NOVO B)-医療機器分野：企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • G&W Electric Company：企業の戦略的SWOT分析
    G&W Electric Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • SpineGuard SA (ALSGD)：医療機器：M&Aディール及び事業提携情報
    Summary SpineGuard SA (SpineGuard) is a medical device company that designs, develops and markets spine surgery products. The company offers PediGuard, a device that detects possible vertebral cortex perforation during pedicle preparation. It provides offers screw placement and alerts to surgeon pri …
  • Piller Group GmbH：企業の戦略的SWOT分析
    Piller Group GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • SATT South East SAS-製薬・医療分野：企業M&A・提携分析
    Summary SATT South East SAS (SATT South East), formerly Satt Paca Corse SAS, a subsidiary of SATT Association is a business and consumer services company that offers technology transfer services. The company offers invention disclosure, intellectual property management, economic market, technology c …
  • OBJ Ltd (OBJ)-医療機器分野：企業M&A・提携分析
    Summary OBJ Ltd (OBJ) is a developer of magnetic micro-array drug and ingredient delivery technologies. The company offers services such as drug or ingredient profiling in skin, laboratory facilities and capabilities, formulation development, product development, product optimisation, and pre-commer …
  • Crossject SA (ALCJ)-医療機器分野：企業M&A・提携分析
    Summary Crossject SA (Crossject) is a medical device company that develops injection systems. The company offers products which include methotrexate, epinephrin, sumatriptan, L15, naloxone, apomorphine, and midazolam. It uses its needle-free injection system to develop a pipeline of supergenerics by …
  • Lietuvos energijos gamyba, AB (LNR1L)：企業の財務・戦略的SWOT分析
    Lietuvos energijos gamyba, AB (LNR1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Mediaset SpA (MS)：企業の財務・戦略的SWOT分析
    Mediaset SpA (MS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • WGL Holdings Inc (WGL)：石油・ガス：M&Aディール及び事業提携情報
    Summary WGL Holdings Inc (WGL) is an energy holding company that delivers natural gas, and provides energy-related products and services to customers. It also offers design-build energy efficient and sustainable solutions and water and energy-related infrastructure services. The company delivers an …
  • Belfius Bank SA：企業の戦略・SWOT・財務情報
    Belfius Bank SA - Strategy, SWOT and Corporate Finance Report Summary Belfius Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Western Digital Corporation：企業の戦略・SWOT・財務情報
    Western Digital Corporation - Strategy, SWOT and Corporate Finance Report Summary Western Digital Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • OncoMed Pharmaceuticals Inc (OMED)：製薬・医療：M&Aディール及び事業提携情報
    Summary OncoMed Pharmaceuticals Inc (OncoMed) is a clinical-stage biopharmaceutical company focused on discovery and development of novel immuno-oncology (IO) therapeutics for the treatment of cancers. Its pipeline product candidates include navicixizumab, rosmantuzumab, Gitrl-FC Trimer, and anti-TI …
  • Trethera Corp：製薬・医療：M&Aディール及び事業提携情報
    Summary Trethera Corp (Trethera), formerly Triangle Therapeutics Inc is a clinical-stage biopharmaceutical company that discovers and develops novel therapies and treatment strategies in oncology. The corporation’s lead program combines TRE-515, a novel deoxycytidine kinase inhibitor with Triapine, …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆